JP6551857B1 - Prefilled syringe exhibiting excellent hydrogen peroxide storage properties - Google Patents

Prefilled syringe exhibiting excellent hydrogen peroxide storage properties Download PDF

Info

Publication number
JP6551857B1
JP6551857B1 JP2019022388A JP2019022388A JP6551857B1 JP 6551857 B1 JP6551857 B1 JP 6551857B1 JP 2019022388 A JP2019022388 A JP 2019022388A JP 2019022388 A JP2019022388 A JP 2019022388A JP 6551857 B1 JP6551857 B1 JP 6551857B1
Authority
JP
Japan
Prior art keywords
hydrogen peroxide
syringe
peroxide solution
solution
resin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2019022388A
Other languages
Japanese (ja)
Other versions
JP2020081835A (en
Inventor
正悟 山下
正悟 山下
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kortuc Inc
Original Assignee
Kortuc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kortuc Inc filed Critical Kortuc Inc
Application granted granted Critical
Publication of JP6551857B1 publication Critical patent/JP6551857B1/en
Priority to SG11202105068YA priority Critical patent/SG11202105068YA/en
Priority to KR1020217012673A priority patent/KR102574226B1/en
Priority to BR112021007680-8A priority patent/BR112021007680A2/en
Priority to PE2021000509A priority patent/PE20211252A1/en
Priority to AU2019378353A priority patent/AU2019378353B2/en
Priority to UAA202102225A priority patent/UA127692C2/en
Priority to CN201980069741.6A priority patent/CN112955199A/en
Priority to CA3119715A priority patent/CA3119715A1/en
Priority to MX2021004248A priority patent/MX2021004248A/en
Priority to PCT/JP2019/041116 priority patent/WO2020100525A1/en
Priority to EP19885559.5A priority patent/EP3708204A4/en
Priority to TW110107157A priority patent/TW202144031A/en
Priority to TW108141176A priority patent/TWI785286B/en
Priority to US16/879,589 priority patent/US20200345946A1/en
Publication of JP2020081835A publication Critical patent/JP2020081835A/en
Priority to IL282203A priority patent/IL282203A/en
Priority to CL2021000911A priority patent/CL2021000911A1/en
Priority to ZA2021/03427A priority patent/ZA202103427B/en
Priority to US17/469,289 priority patent/US20210402101A1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

【課題】過酸化水素の分解を抑制するシリンジを提供する。【解決手段】過酸化水素溶液用シリンジ10であって、上記シリンジと上記過酸化水素溶液50とが直接接触する部分のシリンジ材質が樹脂であって、上記樹脂は、上記過酸化水素溶液中の過酸化水素の分解能がガラスよりも低い、シリンジ。【選択図】図1A syringe for suppressing the decomposition of hydrogen peroxide is provided. A syringe material for a hydrogen peroxide solution, wherein a syringe material of a portion where the syringe and the hydrogen peroxide solution are in direct contact is a resin, and the resin is contained in the hydrogen peroxide solution. Syringe with lower hydrogen peroxide resolution than glass. [Selection] Figure 1

Description

本発明は、シリンジ、特に、過酸化水素溶液の分解能がガラスよりも低いシリンジに関する。   The present invention relates to a syringe, and more particularly to a syringe in which the resolution of a hydrogen peroxide solution is lower than that of glass.

過酸化水素溶液は、工業的には漂白剤として使用され、食品分野では殺菌剤として使用されている。過酸化水素を2.5から3.5 w/v%含むオキシドールは、消毒剤として医療用に用いられている。   Hydrogen peroxide solution is industrially used as a bleaching agent and in the food field as a bactericide. Oxydol containing hydrogen peroxide 2.5 to 3.5 w / v% is used for medical treatment as a disinfectant.

過酸化水素溶液は、ヒアルロン酸と組み合わせることで放射線増感剤として用いることができる(特許文献1)。   A hydrogen peroxide solution can be used as a radiosensitizer by combining it with hyaluronic acid (Patent Document 1).

WO2008/041514WO2008 / 041514

特許文献1のように過酸化水素溶液を放射線増感剤で使用する場合、容易に分解される過酸化水素溶液の特性上、過酸化水素溶液は、使用時に容器から量り取る必要があった。   When a hydrogen peroxide solution is used as a radiation sensitizer as in Patent Document 1, the hydrogen peroxide solution needs to be weighed out of the container at the time of use because of the characteristics of the hydrogen peroxide solution that is easily decomposed.

また、過酸化水素溶液は従来のガラス(材質はホウケイ酸ガラス等)製シリンジを用いてプレフィルド化すると、保存中に膨張したり、ガスケットが押し戻されたりする問題が生じ、長期保存が不可能であった。この課題を解決するために本発明は、長期保存可能な過酸化水素溶液用プレフィルドシリンジを提供する。   In addition, if the hydrogen peroxide solution is pre-filled using a conventional glass (borosilicate glass etc.) syringe, it causes problems such as expansion during storage and pushing back of the gasket, making long-term storage impossible. there were. In order to solve this problem, the present invention provides a prefilled syringe for hydrogen peroxide solution that can be stored for a long time.

本発明の目的は、
過酸化水素溶液用シリンジであって、
上記シリンジと上記過酸化水素溶液とが直接接触する部分のシリンジ材質が樹脂であって、
上記樹脂は、上記過酸化水素溶液中の過酸化水素の分解能がガラスよりも低い、シリンジを提供することである。
The purpose of the present invention is to
A syringe for hydrogen peroxide solution,
The syringe material of the portion where the above-mentioned syringe and the above-mentioned hydrogen peroxide solution are in direct contact is resin,
The resin is to provide a syringe in which the resolution of hydrogen peroxide in the hydrogen peroxide solution is lower than that of glass.

このシリンジを用いることで、過酸化水素溶液中の過酸化水素の分解を抑制することが可能になり、例えば、過酸化水素溶液をプレフィルドしたシリンジであっても長期間の保存が可能になると考えられる。   By using this syringe, it is possible to suppress the decomposition of hydrogen peroxide in the hydrogen peroxide solution, and it is considered that, for example, even a syringe in which the hydrogen peroxide solution is prefilled can be stored for a long time It is done.

この発明により、過酸化水素溶液を長期保存可能な放射線増感剤用プレフィルドシリンジが提供可能となる。   According to the present invention, it is possible to provide a prefilled syringe for a radiosensitizer capable of storing hydrogen peroxide solution for a long time.

図1は、本実施形態による、過酸化水素溶液が充填されたプレフィルドシリンジの概略図を示している。FIG. 1 shows a schematic view of a prefilled syringe filled with a hydrogen peroxide solution according to the present embodiment. 図2は、実施例における各シリンジ材質の過酸化水素残存率のグラフを示している。FIG. 2 shows a graph of the hydrogen peroxide remaining rate of each syringe material in the example.

定義
便宜上、本願で使用される特定の用語は、ここに集めている。別途規定されない限り、本願で使用される全ての技術用語及び科学用語は、本発明が属する技術分野の当業者が一般的に理解するのと同じ意味を有する。文脈で別途明記されない限り、単数形「a」、「an」及び「the」は複数の言及を含む。
Definitions For convenience, certain terms used in the present application are collected here. Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. The singular forms "a", "an" and "the" include plural references unless the context clearly dictates otherwise.

本発明で示す数値範囲及びパラメーターは、近似値であるが、特定の実施例に示されている数値は可能な限り正確に記載している。しかしながら、いずれの数値も本質的に、それぞれの試験測定値に見られる標準偏差から必然的に生じる特定の誤差を含んでいる。また、本明細書で使用する「約」という用語は、一般に、所与の値又は範囲の10%、5%、1%又は0.5%以内を意味する。或いは、用語「約」は、当業者が考慮する場合、許容可能な標準誤差内にあることを意味する。   The numerical ranges and parameters indicated in the present invention are approximate, but the numerical values shown in the specific examples are described as accurately as possible. Any numerical value, however, inherently contains certain errors necessarily resulting from the standard deviation found in their respective testing measurements. Also, as used herein, the term “about” generally means within 10%, 5%, 1% or 0.5% of a given value or range. Alternatively, the term “about” means within an acceptable standard error, as considered by one of ordinary skill in the art.

シリンジ
本実施形態にかかるシリンジは、
過酸化水素溶液用シリンジであって、
上記シリンジと上記過酸化水素溶液とが直接接触する部分のシリンジ材質が樹脂であって、
上記樹脂は、上記過酸化水素溶液中の過酸化水素の分解能がガラスよりも低い。
Syringe The syringe according to this embodiment is
A syringe for hydrogen peroxide solution,
The syringe material of the portion where the above-mentioned syringe and the above-mentioned hydrogen peroxide solution are in direct contact is resin,
The resin has lower resolution of hydrogen peroxide in the hydrogen peroxide solution than glass.

図1は、本実施形態による、過酸化水素溶液50が充填されたプレフィルドシリンジ1の概略図を示している。本実施形態において、シリンジ10、特にバレル20の形状は、一般的には、円筒形であり、シリンジ10の一端には、過酸化水素溶液50が排出される針装着部30を備え、シリンジ10の他端には、プランジャーロッド70を挿入するための開口部80を備え、開口部80周辺には、フランジ90を備える。図1に示すプレフィルドシリンジ1は、充填された過酸化水素溶液50を密閉するために、針装着部30にはキャップ40が備わり、開口部80からガスケット60を備えるプランジャーロッド70が挿入されている。   FIG. 1 shows a schematic view of a prefilled syringe 1 filled with a hydrogen peroxide solution 50 according to the present embodiment. In the present embodiment, the shape of the syringe 10, particularly the barrel 20, is generally cylindrical, and the syringe 10 is provided with a needle mounting part 30 through which the hydrogen peroxide solution 50 is discharged at one end of the syringe 10. At the other end of the frame, an opening 80 for inserting the plunger rod 70 is provided, and around the opening 80, a flange 90 is provided. In the prefilled syringe 1 shown in FIG. 1, in order to seal the filled hydrogen peroxide solution 50, the needle mounting portion 30 is provided with a cap 40, and a plunger rod 70 provided with a gasket 60 is inserted from the opening 80. Yes.

本実施形態において、過酸化水素溶液用シリンジとは、過酸化水素溶液中の過酸化水素の分解能が低いシリンジを意味する。本実施形態において、過酸化水素溶液は、過酸化水素を溶媒(例えば、水)に溶かした溶液を意味し、必要に応じて、添加物(例えば、リン酸及びフェナセチン)を含有していてもよい。本実施形態において、シリンジは、単一の材質から製造されていてもよく、複数の材質(コーティング等の多層構造を含む)から構成されていてもよい。単一の材質から製造されたシリンジの場合、シリンジ全体が上記樹脂でできている。複数の材質から構成されたシリンジの場合、シリンジと過酸化水素溶液とが直接接触する部分が上記樹脂でできており、他の部分は、ガラス等の過酸化水素の分解能が高い材質でできていてもよい。また、過酸化水素溶液と接触するすべての部分が上記樹脂でできている必要はなく、シリンジ本体のバレルの内面を始めとする主な部分が上記樹脂で出来ていればよい。すなわち、他にも過酸化水素溶液と接触する可能性がある、プランジャーロッド、ルアーロック、キャップ、ガスケットなどは、上記樹脂でできている必要はない。また、シリンジ本体のバレルの内面に塗布されることもある、シリコーンオイルなどの潤滑剤についても、上記樹脂でできている必要はない。   In this embodiment, the syringe for hydrogen peroxide solution means a syringe having a low resolution of hydrogen peroxide in the hydrogen peroxide solution. In this embodiment, the hydrogen peroxide solution means a solution in which hydrogen peroxide is dissolved in a solvent (for example, water), and may contain additives (for example, phosphoric acid and phenacetin) as necessary. Good. In the present embodiment, the syringe may be manufactured from a single material or may be composed of a plurality of materials (including a multilayer structure such as a coating). In the case of a syringe manufactured from a single material, the entire syringe is made of the resin. In the case of a syringe composed of a plurality of materials, the portion where the syringe and the hydrogen peroxide solution are in direct contact is made of the above resin, and the other portion is made of a material having high hydrogen peroxide resolution such as glass. May be. Further, it is not necessary that all the parts that come into contact with the hydrogen peroxide solution are made of the resin, and it is only necessary that the main part including the inner surface of the barrel of the syringe body is made of the resin. That is, other plunger rods, luer locks, caps, gaskets, and the like that may come into contact with the hydrogen peroxide solution need not be made of the resin. Also, a lubricant such as silicone oil that may be applied to the inner surface of the barrel of the syringe body does not need to be made of the resin.

過酸化水素の分解能は、保存開始前の過酸化水素溶液中の過酸化水素の濃度に対する特定の温度条件下での特定の保存期間後の過酸化水素溶液中の過酸化水素の濃度の割合(過酸化水素残存率)から決定することができる。保存は、密閉状態で行われる。温度条件は、限定するものではないが、35℃、37℃、40℃、又は60℃であってもよい。保存期間は、限定するものではないが、1週間、2週間、3週間又は4週間であってもよく、4週間以上であってもよい。保存開始前の過酸化水素溶液中の過酸化水素の濃度は、例えば、0.01から40%(v/v)の範囲の任意の濃度で試験してもよい。実施形態において、上記樹脂の過酸化水素の分解能は、ガラスよりも低ければよい。上記樹脂の過酸化水素残存率は、過酸化水素2.5〜3.5w/v%を含有する溶液を60℃4週間密閉保管する条件下で、70%以上、好ましくは75%以上、より好ましくは78%以上、更に好ましくは80%以上であればよい。過酸化水素溶液中の過酸化水素量は、日本薬局方のオキシドール定量法に従い、過マンガン酸カリウム液で滴定することによって求めることができる。   The resolution of hydrogen peroxide is the ratio of the concentration of hydrogen peroxide in the hydrogen peroxide solution after a specific storage period under specific temperature conditions to the concentration of hydrogen peroxide in the hydrogen peroxide solution before storage begins ( It can be determined from the hydrogen peroxide residual rate). Storage is performed in a closed state. Temperature conditions may be, but are not limited to, 35 ° C, 37 ° C, 40 ° C, or 60 ° C. The storage period is not limited, but may be 1 week, 2 weeks, 3 weeks or 4 weeks, or 4 weeks or more. The concentration of hydrogen peroxide in the hydrogen peroxide solution before the start of storage may be tested at any concentration in the range of 0.01 to 40% (v / v), for example. In the embodiment, it is sufficient that the resolution of hydrogen peroxide of the resin is lower than that of glass. The residual hydrogen peroxide ratio of the resin is 70% or more, preferably 75% or more, more preferably 78%, under the condition that a solution containing hydrogen peroxide 2.5 to 3.5 w / v% is hermetically stored at 60 ° C. for 4 weeks. % Or more, more preferably 80% or more. The amount of hydrogen peroxide in the hydrogen peroxide solution can be determined by titration with a potassium permanganate solution according to the Japanese Pharmacopoeia oxidol determination method.

本実施形態において、上記樹脂は、シクロオレフィンポリマー(COP)、シクロオレフィンコポリマー(COC)及びポリプロピレンを例示することができるが、上記樹脂は、ガラスよりも低い過酸化水素の分解能を有するのであれば、これらに限定するものではない。   In the present embodiment, the resin can be exemplified by cycloolefin polymer (COP), cycloolefin copolymer (COC) and polypropylene, but if the resin has lower hydrogen peroxide resolution than glass Not limited to these.

本実施形態のシリンジは、過酸化水素溶液がプレフィルドされたシリンジとして提供してもよい。過酸化水素溶液がプレフィルドされたシリンジは、シリンジの摺動可能に備えられたガスケットを備える。また、過酸化水素溶液がプレフィルドされたシリンジは、針装着部は(例えば、キャップなどによって)封止されている。   The syringe of the present embodiment may be provided as a syringe in which a hydrogen peroxide solution is prefilled. The syringe with the hydrogen peroxide solution pre-filled comprises a slidably mounted gasket of the syringe. Moreover, the needle mounting part of the syringe prefilled with the hydrogen peroxide solution is sealed (for example, with a cap or the like).

本実施形態において、プレフィルドされたシリンジにおける過酸化水素溶液中の過酸化水素の濃度は、例えば、0.01、0.02、0.03、0.04、0.05、0.06、0.07、0.08、0.09、0.1、0.5、1、5、10、15、20、25、30、35又は40%であり、ここで例示した数値の何れか2つの間の範囲内であってもよく、例えば、0.01から40%(v/v)、好ましくは、0.05から30%(v/v)である。   In the present embodiment, the concentration of hydrogen peroxide in the hydrogen peroxide solution in the prefilled syringe is, for example, 0.01, 0.02, 0.03, 0.04, 0.05, 0.06, 0.07, 0.08, 0.09, 0.1, 0.5, 1, 5 , 10, 15, 20, 25, 30, 35 or 40%, and may be in the range between any two of the numerical values exemplified herein, for example, 0.01 to 40% (v / v), Preferably, it is 0.05 to 30% (v / v).

過酸化水素溶液の安定性試験
ガラス製シリンジ、COP製シリンジ及びCOC製シリンジを用いて、過酸化水素溶液の安定性試験を行った。各シリンジに過酸化水素溶液を1mL加えて密閉し、60℃4週間にて保管した。保管後の過酸化水素溶液中の過酸化水素の残存率を測定した。過酸化水素溶液は、健栄製薬社製オキシドール「ケンエー」(過酸化水素2.5〜3.5w/v%を含有。リン酸、フェナセチン含有)を用いた。過酸化水素溶液中の過酸化水素量は、日本薬局方のオキシドール定量法に従い、過マンガン酸カリウム液で滴定にて検出した。
Stability Test of Hydrogen Peroxide Solution The stability test of the hydrogen peroxide solution was conducted using a glass syringe, a COP syringe and a COC syringe. 1 mL of hydrogen peroxide solution was added to each syringe and sealed, and stored at 60 ° C. for 4 weeks. The residual ratio of hydrogen peroxide in the hydrogen peroxide solution after storage was measured. As the hydrogen peroxide solution, Oxole “KENA” (containing 2.5 to 3.5 w / v% hydrogen peroxide, containing phosphoric acid and phenacetin) manufactured by Kenei Pharmaceutical Co., Ltd. was used. The amount of hydrogen peroxide in the hydrogen peroxide solution was detected by titration with a potassium permanganate solution according to the oxydol determination method of the Japanese Pharmacopoeia.

結果を図2に示す。ガラスの場合は、過酸化水素残存率が70%未満である一方で、COP及びCOCは70%以上であった。以上の結果、COP製及びCOC製シリンジは、ガラス製シリンジよりも過酸化水素の分解を抑制することができた。   The results are shown in FIG. In the case of glass, COP and COC were 70% or more while hydrogen peroxide residual rate was less than 70%. As a result of the above, COP and COC syringes were able to suppress the decomposition of hydrogen peroxide more than glass syringes.

1 プレフィルドシリンジ
10 シリンジ
20 バレル
30 針装着部
40 キャップ
50 過酸化水素溶液
60 ガスケット
70 プランジャーロッド
80 開口部
90 フランジ
1 Prefilled syringe
10 syringe
20 barrels
30 Needle mount
40 cap
50 Hydrogen peroxide solution
60 Gasket
70 Plunger rod
80 opening
90 flange

Claims (2)

過酸化水素溶液がプレフィルドされた過酸化水素溶液用シリンジであって、
前記シリンジと前記過酸化水素溶液とが直接接触する部分のシリンジ材質がシクロオレフィンポリマー(COP)又はシクロオレフィンコポリマー(COC)であり、
前記過酸化水素溶液は、過酸化水素を水に溶かした溶液であって、必要に応じて、添加物を含有することができる溶液である、シリンジ。
A syringe for hydrogen peroxide solution with hydrogen peroxide solution prefilled,
The syringe material of the portion where the syringe and the hydrogen peroxide solution are in direct contact with each other is cycloolefin polymer (COP) or cycloolefin copolymer (COC),
The syringe , wherein the hydrogen peroxide solution is a solution in which hydrogen peroxide is dissolved in water, and can optionally contain an additive .
前記過酸化水素溶液の前記過酸化水素の濃度は、0.01から40%(v/v)である、請求項に記載のシリンジ。 The syringe according to claim 1 , wherein the concentration of hydrogen peroxide in the hydrogen peroxide solution is 0.01 to 40% (v / v).
JP2019022388A 2018-11-16 2019-02-12 Prefilled syringe exhibiting excellent hydrogen peroxide storage properties Active JP6551857B1 (en)

Priority Applications (18)

Application Number Priority Date Filing Date Title
EP19885559.5A EP3708204A4 (en) 2018-11-16 2019-10-18 Syringe suitable for hydrogen peroxide solution, and kit
PCT/JP2019/041116 WO2020100525A1 (en) 2018-11-16 2019-10-18 Syringe suitable for hydrogen peroxide solution, and kit
KR1020217012673A KR102574226B1 (en) 2018-11-16 2019-10-18 Syringes and kits suitable for hydrogen peroxide solutions
BR112021007680-8A BR112021007680A2 (en) 2018-11-16 2019-10-18 syringe and kit
PE2021000509A PE20211252A1 (en) 2018-11-16 2019-10-18 SUITABLE SYRINGE FOR HYDROGEN PEROXIDE SOLUTION AND SAME KIT
AU2019378353A AU2019378353B2 (en) 2018-11-16 2019-10-18 Syringe suitable for hydrogen peroxide solution, and kit
UAA202102225A UA127692C2 (en) 2018-11-16 2019-10-18 Syringe suitable for hydrogen peroxide solution, and kit
CN201980069741.6A CN112955199A (en) 2018-11-16 2019-10-18 Syringe and kit suitable for hydrogen peroxide solution
CA3119715A CA3119715A1 (en) 2018-11-16 2019-10-18 Syringe suitable for hydrogen peroxide solution and kit thereof
MX2021004248A MX2021004248A (en) 2018-11-16 2019-10-18 Syringe suitable for hydrogen peroxide solution, and kit.
SG11202105068YA SG11202105068YA (en) 2018-11-16 2019-10-18 Syringe suitable for hydrogen peroxide solution, and kit
TW108141176A TWI785286B (en) 2018-11-16 2019-11-13 Syringe and kit suitable for inhibiting decomposition of hydrogen peroxide solution, and preparation method and preservation method of hydrogen peroxide for inhibiting decomposition of hydrogen peroxide solution
TW110107157A TW202144031A (en) 2018-11-16 2019-11-13 Syringe suitable for hydrogen peroxide solution, and kit
US16/879,589 US20200345946A1 (en) 2018-11-16 2020-05-20 Syringe suitable for hydrogen peroxide solution and kit thereof
IL282203A IL282203A (en) 2018-11-16 2021-04-09 Syringe suitable for hydrogen peroxide solution, and kit
CL2021000911A CL2021000911A1 (en) 2018-11-16 2021-04-13 Suitable syringe for hydrogen peroxide solution and kit of the same.
ZA2021/03427A ZA202103427B (en) 2018-11-16 2021-05-20 Syringe suitable for hydrogen peroxide solution and kit thereof
US17/469,289 US20210402101A1 (en) 2018-11-16 2021-09-08 Stabilization of hydrogen peroxide solution in filled syringes

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2018215913 2018-11-16
JP2018215913 2018-11-16

Publications (2)

Publication Number Publication Date
JP6551857B1 true JP6551857B1 (en) 2019-07-31
JP2020081835A JP2020081835A (en) 2020-06-04

Family

ID=67473377

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019022388A Active JP6551857B1 (en) 2018-11-16 2019-02-12 Prefilled syringe exhibiting excellent hydrogen peroxide storage properties

Country Status (3)

Country Link
JP (1) JP6551857B1 (en)
AR (1) AR117082A1 (en)
MA (1) MA53454B1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020195501A (en) * 2019-05-31 2020-12-10 株式会社Kortuc Radiosensitizer or anticancer chemotherapeutic sensitizer administration holder
JP2021000262A (en) * 2019-06-21 2021-01-07 株式会社Kortuc Syringe and kit suitable for hydrogen peroxide solution

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4324501A1 (en) * 2021-04-15 2024-02-21 Alteogen, Inc Pre-filled syringe filled with low-dose liquid medicine, and preparation method therefor
CN117320772A (en) 2022-03-31 2023-12-29 日本合同会社Kortuc Sealing body for syringe

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4526148B2 (en) * 2000-01-20 2010-08-18 アイセロ化学株式会社 Container for liquid containing hydrogen peroxide
JP2001341794A (en) * 2000-05-31 2001-12-11 Sumitomo Chem Co Ltd Ultrapure hydrogen peroxide solution container
US20020139088A1 (en) * 2001-03-08 2002-10-03 Archie Woodworth Polymeric syringe body and stopper
JP2003267706A (en) * 2002-03-15 2003-09-25 Mitsubishi Gas Chem Co Inc Preservation vessel for hydrogen peroxide aqueous solution
JP2007008874A (en) * 2005-06-30 2007-01-18 Gc Corp Pasty dental bleaching material
US10219997B2 (en) * 2006-09-22 2019-03-05 Kochi University Radiation sensitizer or anti-cancer chemotherapy sensitizer
JP2014057632A (en) * 2012-09-14 2014-04-03 Mitsubishi Gas Chemical Co Inc Medical multilayer container

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020195501A (en) * 2019-05-31 2020-12-10 株式会社Kortuc Radiosensitizer or anticancer chemotherapeutic sensitizer administration holder
JP2021000262A (en) * 2019-06-21 2021-01-07 株式会社Kortuc Syringe and kit suitable for hydrogen peroxide solution

Also Published As

Publication number Publication date
JP2020081835A (en) 2020-06-04
MA53454B1 (en) 2023-08-31
AR117082A1 (en) 2021-07-07
MA53454A1 (en) 2022-08-31

Similar Documents

Publication Publication Date Title
JP6551857B1 (en) Prefilled syringe exhibiting excellent hydrogen peroxide storage properties
ITMI950988A1 (en) PROCESS FOR THE PRODUCTION OF PRE-FILLED SYRINGES WITHOUT RESIDUAL GAS BUBBLES
US20170216531A1 (en) Cryosyringe designed for sterile liquid nitrogen freezing, quick thawing and injection of cellular slurries
KR101688685B1 (en) Pre-filled syringe
DK3124026T3 (en) INJECTION PREPARATION AND METHOD OF PREPARING IT
EP3735214A1 (en) Mixing vial
CA2864740A1 (en) Infusates with enhanced ph stability under ethylene oxide sterilization
JPH0295380A (en) Radioactive solution injecting cylinder and container for transporting and storing this cylinder
JP6635454B1 (en) Hydrogen peroxide solution prefilled glass syringe showing excellent hydrogen peroxide preservation due to silicone oil (containing oil composition)
JPWO2016002686A1 (en) Pharmaceutical containers and pharmaceutical preparations
EA202190388A1 (en) LIQUID DOSE FORM OF EDARAVON OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS, STABLE DURING STORAGE, TRANSPORTATION AND USE
JP5435797B2 (en) Blood collection tube and pharmaceutical composition for measuring blood glucose level and / or hemoglobin A1c level
JP6651155B1 (en) Syringe and kit suitable for hydrogen peroxide solution
WO2020100525A1 (en) Syringe suitable for hydrogen peroxide solution, and kit
KR102604124B1 (en) Pre-filled syringe with hydrogen peroxide solution exhibiting excellent hydrogen peroxide retention properties due to silicone oil (oil composition containing)
JP2020200207A (en) Oil composition for stabilizing storage of hydrogen peroxide
JP2017066073A (en) Aqueous formulations for injection used in treatment of inflammatory autoimmune disease and storage methods thereof
JP2020195501A (en) Radiosensitizer or anticancer chemotherapeutic sensitizer administration holder
JP2001029467A (en) Plunger having radioshielding plate for radioactive solution syringe
JP5351480B2 (en) Water filled prefilled syringe for injection
JP2003054615A (en) Seaming lid, and vessel using the same
JP2022035087A (en) Sugammadex-containing liquid formulation
CA3219747A1 (en) Syringe sealing
GB1043390A (en) Double ampoule, hypodermic syringe or part of same
JPH06154324A (en) Gasket

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20190213

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20190213

A975 Report on accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A971005

Effective date: 20190307

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190312

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190410

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20190423

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20190425

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20190621

R150 Certificate of patent or registration of utility model

Ref document number: 6551857

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250